Time-resolved phenotypic profiling maps EGFR and c-Met trafficking signatures

Kenji Tanabe1

  • 1Institute for Comprehensive Medical Sciences, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. tanabe.kenji@twmu.ac.jp.

Scientific Reports
|July 18, 2026
PubMed
Summary

Investigating receptor tyrosine kinases (RTKs) like EGFR and c-Met reveals how their trafficking impacts cancer. Different RTK persistence states link to distinct lipid signaling, offering new therapeutic targets.